https://www.mangaloremirror.com/plus-therapeutics-to-host-investor-call-to-discuss-leptomeningeal-cancer-related-acquisition-and-topline-clinical-trial-data-from-the-foresee-trial/
Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial